Pfizer Inc (MIL:1PFE)
€ 24.625 -0.215 (-0.87%) Market Cap: 139.23 Bil Enterprise Value: 192.39 Bil PE Ratio: 35.39 PB Ratio: 1.61 GF Score: 64/100

Pfizer Inc at Evercore ISI HealthCONx Virtual Conference Transcript

Dec 01, 2021 / 10:10PM GMT
Umer Raffat
Evercore ISI Institutional Equities, Research Division - Senior MD & Senior Analyst of Equity Research

Hello, everyone. Thank you for joining us. Pleasure to have Pfizer management join us. There's a lot to talk about, but at the outset, I do want to say that when we were first scheduling this event, there was a lot of interest at Pfizer at the time. And this was -- we were doing this in the -- in -- during the summer, and there was a lot of interest at Pfizer at the time to talk about some of the innovation areas that aren't getting necessarily much Street focus, which included obviously an emerging gene therapy pipeline. And one of the goals at this fireside when we were first setting it up was to have Bob Smith, who's -- who could really take us through the gene therapy business in a lot of detail. But of course, we couldn't have predicted that 3 days before this fireside chat, there would obviously be a new and crazy variant.

So in light of that, we're going to start off with a few variant questions, if that's okay. But let me first turn it over to Chris, who's the new head

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot